基本信息
views: 150
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Professor Sanjay Garg is a highly accomplished pharmaceutical scientist with a wealth of experience and expertise in translational drug discovery, development, and delivery. He is a respected leader in the field and a true visionary when it comes to making a positive impact on patients' lives. He is committed to advancing the field through cutting-edge research and innovative solutions. Several of his patented formulations have reached clinical stages and market in the USA, India, New Zealand, UK, and Australia, e.g., Acidform (USA Patent 6706276) has been approved by US FDA as a non-hormonal contraceptive (Phexxi) and is marketed in the USA.
Research Focus
Prof. Garg's current research focuses on several critical areas of importance, including:
Anti-cancer Drug Targeting: His team is exploring both local and systemic delivery of drugs, with a focus on 3D printing for localized drug targeting.
Infections: In collaboration with several leading researchers, Prof. Garg is working on the development of novel antimicrobial compounds and formulations for both human and veterinary applications, resulting in successful patents and products for treating bacterial, protozoal, and fungal infections.
Veterinary Delivery Systems: His team is rapidly developing expertise in veterinary drug delivery, including innovative formulations for cattle, horses, pigs, cats, dogs, and fish.
Other Patient-centric Projects: Prof. Garg continues to work on projects that directly benefit patients, such as extemporaneous compounding and analysis of drugs in human milk.
Research Focus
Prof. Garg's current research focuses on several critical areas of importance, including:
Anti-cancer Drug Targeting: His team is exploring both local and systemic delivery of drugs, with a focus on 3D printing for localized drug targeting.
Infections: In collaboration with several leading researchers, Prof. Garg is working on the development of novel antimicrobial compounds and formulations for both human and veterinary applications, resulting in successful patents and products for treating bacterial, protozoal, and fungal infections.
Veterinary Delivery Systems: His team is rapidly developing expertise in veterinary drug delivery, including innovative formulations for cattle, horses, pigs, cats, dogs, and fish.
Other Patient-centric Projects: Prof. Garg continues to work on projects that directly benefit patients, such as extemporaneous compounding and analysis of drugs in human milk.
Research Interests
Papers共 598 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
International journal of pharmaceutics (2024): 123790-123790
Drug Delivery and Translational Researchno. 4 (2024): 984-1004
International Journal of Pharmaceutics (2024): 124314-124314
PHARMACEUTICSno. 3 (2024): 379
BIOREMEDIATION JOURNALno. 1 (2024): 110-120
Frontiers in Drug Delivery (2024)
DRUG DESIGN DEVELOPMENT AND THERAPY (2024): 899-908
Riya Khetan,Preethi Eldi,Noor A. Lokman,Carmela Ricciardelli, Martin K. Oehler,Anton Blencowe,Sanjay Garg,Katherine Pillman, Hugo Albrecht
Journal of Ovarian Researchno. 1 (2024): 1-13
Load More
Author Statistics
#Papers: 601
#Citation: 19838
H-Index: 65
G-Index: 117
Sociability: 7
Diversity: 4
Activity: 185
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn